Finch Therapeutics Group, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
15-12G
25
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 15-12G | 15-12G | 0001193125-24-255195 | Nov 12, 2024 | — |
| EFFECT | — | 9999999995-24-003352 | Nov 4, 2024 | — |
| POS AM | POS AM | 0001193125-24-249236 | Nov 1, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-249235 | Nov 1, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-249234 | Nov 1, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-249233 | Nov 1, 2024 | — |
| 25 | 25 | 0001193125-24-248169 | Oct 31, 2024 | — |
| 8-K | 8-K | 0001193125-24-240034 | Oct 21, 2024 | Oct 17, 2024 |
| 10-Q | 10-Q | 0000950170-24-096246 | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001193125-24-198362 | Aug 12, 2024 | Aug 9, 2024 |
| 4 | 4 | 0000950170-24-071496 | Jun 10, 2024 | Jun 7, 2024 |
| 4 | 4 | 0000950170-24-064850 | May 24, 2024 | May 20, 2024 |
| 8-K | 8-K | 0001193125-24-146454 | May 24, 2024 | May 23, 2024 |
| 8-K | 8-K | 0001193125-24-141816 | May 17, 2024 | May 14, 2024 |
| 10-Q | 10-Q | 0000950170-24-057912 | May 10, 2024 | Mar 31, 2024 |
| 10-K/A | 10-K/A | 0000950170-24-049269 | Apr 26, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001193125-24-085435 | Apr 3, 2024 | Mar 28, 2024 |
| 4 | 4 | 0000950170-24-038657 | Mar 29, 2024 | Mar 28, 2024 |
| 144 | — | 0001958244-24-001152 | Mar 28, 2024 | — |
| 10-K | 10-K | 0000950170-24-035952 | Mar 25, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001193125-24-044511 | Feb 23, 2024 | Feb 16, 2024 |
| SC 13G | SCHEDULE 13G | 0001014108-23-000151 | Dec 13, 2023 | — |
| 4 | 4 | 0000950170-23-066155 | Nov 27, 2023 | Nov 22, 2023 |
| 144 | — | 0001958244-23-002311 | Nov 22, 2023 | — |
| 8-K | 8-K | 0001193125-23-279821 | Nov 17, 2023 | Nov 15, 2023 |
| 10-Q | 10-Q | 0000950170-23-060651 | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q/A | 10-Q/A | 0000950170-23-041575 | Aug 11, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-040924 | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-183823 | Jul 7, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-177539 | Jun 28, 2023 | Jun 27, 2023 |
| 4/A | FORM 4/A SUBMISSION | 0000899243-23-016365 | Jun 23, 2023 | Jun 9, 2023 |
| 8-K | 8-K | 0001193125-23-173133 | Jun 23, 2023 | Jun 21, 2023 |
| 8-K | 8-K | 0001193125-23-164542 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015198 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015188 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015186 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015183 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015182 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-015177 | Jun 9, 2023 | Jun 8, 2023 |
| 4 | OWNERSHIP DOCUMENT | 0000950142-23-001652 | Jun 9, 2023 | Jun 8, 2023 |
| 8-K | 8-K | 0001193125-23-156571 | May 30, 2023 | May 25, 2023 |
| 8-K | 8-K | 0001193125-23-148134 | May 18, 2023 | May 12, 2023 |
| 3 | FORM 3 SUBMISSION | 0000899243-23-013064 | May 16, 2023 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-23-013062 | May 16, 2023 | — |
| DEFA14A | DEFA14A | 0000950170-23-021250 | May 11, 2023 | — |
| 8-K | 8-K | 0000950170-23-021205 | May 11, 2023 | May 8, 2023 |
| 10-Q | 10-Q | 0000950170-23-020080 | May 10, 2023 | Mar 31, 2023 |
| 8-K | 8-K | 0000950170-23-020075 | May 10, 2023 | — |
| ARS | ARS | 0000950170-23-014781 | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | DEFA14A | 0000950170-23-014777 | Apr 26, 2023 | — |